NCT07156955 Proprioceptive Error Correction for Post-Stroke Upper Limb Rehabilitation
| NCT ID | NCT07156955 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sungkyunkwan University |
| Condition | Ischemic Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 3 participants |
| Start Date | 2026-09-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 3 participants in total. It began in 2026-09-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators aim to develop sensory transformation and augmentation technologies that minimize the impact of proprioceptive errors, thereby significantly enhancing motor learning and rehabilitation of the upper limbs. This study is designed to test proprioceptive error compensation techniques in stroke patients. The human nervous system often receives mismatched information from vision and proprioception during upper limb control, resulting in conflicting sensory inputs that limit the effectiveness of motor learning. In other words, real-time sensory feedback - a critical component of motor learning in the nervous system - is not reliably delivered. Therefore, this study seeks to resolve sensory conflicts by providing additional sensory information through electrical stimulation, with the goal of dramatically improving the effectiveness of motor learning.
Eligibility Criteria
Inclusion Criteria: * Diagnosed with ischemic or hemorrhagic stroke * Stroke confirmed by CT or MRI * Stroke patients with proprioceptive sensory deficits * Chronic stroke patients with onset at least 3 months prior * Able to voluntarily flex and extend the elbow joint * Age 19 years or older * Provide written informed consent (participant or legal representative) Exclusion Criteria: * Severe pain during elbow joint movement * Elbow joint contracture, spasticity, ataxia, musculoskeletal disorders, fractures, - non-healing ulcers, or open wounds * Progressive or unstable stroke * Presence of unilateral neglect * Coexisting severe neurological disorders * Major psychiatric disorders such as major depressive disorder, schizophrenia, bipolar disorder, or dementia Presence of a pacemaker
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07156955 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, studying Ischemic Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07156955 currently recruiting?
Yes, NCT07156955 is actively recruiting participants. Contact the research team at iijjuness@g.skku.edu for enrollment information.
Where is the NCT07156955 trial being conducted?
This trial is being conducted at Seoul, South Korea.
Who is sponsoring the NCT07156955 clinical trial?
NCT07156955 is sponsored by Sungkyunkwan University. The trial plans to enroll 3 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.